Decreased colony formation of high proliferative potential colony-forming cells and granulocyte-macrophage colony-forming units and increased Hes-1 expression in bone marrow mononuclear cells from patients with psoriasis

British Journal of Dermatology

Volumn 163, Issue 1, 2010, Pages 93-101

  Zhang, K ^a   Hou, R ^a   Niu, X ^a   Zhang, J ^a   Yin, G ^a   Li, X ^a   Jia, Y ^b  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b Jinzhong First People's Hospital   (China)

Author keywords

bone marrow haematopoietic cells; granulocyte macrophage colony forming units; HES1; high proliferative potential colony forming cells; psoriasis

Indexed keywords

CYTOKINE; MESSENGER RNA; NOTCH RECEPTOR; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR HES 1;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW; CELL ACTIVITY; CELL COUNT; CELL CULTURE; CELL ISOLATION; CLINICAL ARTICLE; COLONY FORMATION; COLONY FORMING CELL; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GRANULOCYTE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MACROPHAGE; MALE; MICROENVIRONMENT; MONONUCLEAR CELL; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; REVERSE TRANSCRIPTION; SUPERNATANT; TELOMERE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

ADOLESCENT; ADULT; AGED; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELLS, CULTURED; FEMALE; GRANULOCYTE-MACROPHAGE PROGENITOR CELLS; HEMATOPOIETIC STEM CELLS; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PSORIASIS; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; TELOMERASE; YOUNG ADULT;

EID: 77953987060     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09790.x     Document Type: Article

References (48)

1. Austin LM, Ozawa M, Kikuchi T et al. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 1999 113 : 752 759.
2. Schön MP, Boehncke WH. Psoriasis. N Engl J Med 2005 352 : 1899 1912.
3. Zarrabeitia MT, Farinas MC, Rodriguez-Valverde V et al. T and B cell function in psoriasis and psoriatic arthropathy. Allergol Immunopathol (Madr) 1989 17 : 155 159.
4. Schon M, Denzer D, Kubitza RC et al. Critical role of neutrophils for the generation of psoriasiform skin lesions in flaky skin mice. J Invest Dermatol 2000 114 : 976 983.
5. Rocha-Pereira P, Santos-Silva A, Rebelo I et al. Erythrocyte damage in mild and severe psoriasis. Br J Dermatol 2004 150 : 232 244. (Pubitemid 38352460)
6. Clark RA, Kupper TS. Misbehaving macrophages in the pathogenesis of psoriasis. Clin Invest 2006 116 : 2084 2087.
7. Stratis A, Pasparakis M, Rupec RA et al. Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J Clin Invest 2006 116 : 2094 2104.
8. Zhang K, Li X, Yin G et al. Functional characterization of CD4+CD25+ regulatory T cells differentiated in vitro from bone marrow-derived haematopoietic cells of psoriatic patients with a family history of the disorder. Br J Dermatol 2008 158 : 298 305.
9. Sugiyama H, Gyulai R, Toichi E et al. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 2005 174 : 164 173.
10. Ryan DH, Nuccie BL, Ritterman I et al. Cytokine regulation of early human lymphopoiesis. J Immunol 1994 152 : 5250 5258.
11. Altmeyer P, Munz DL, Chilf G et al. Morphological and functional findings of fixed phagocytes in psoriatics. Arch Dermatol Res 1983 275 : 95 9.
12. Meuret G, Schmitt E, Hagedorn M. Monocytopoiesis in chronic eczematous diseases, psoriasis vulgaris, and mycosis fungoides. J Invest Dermatol 1976 66 : 22 8.
13. Palis J, Chan RJ, Koniski A et al. Spatial and temporal emergence of high proliferative potential hematopoietic precursors during murine embryogenesis. Proc Natl Acad Sci USA 2001 98 : 4528 4533.
14. Walkley CR, Orkin SH. Rb is dispensable for self-renewal and multilineage differentiation of adult hematopoietic stem cells. Proc Natl Acad Sci USA 2006 103 : 9057 9062.
15. Bradley TR, Hodgson GS. Detection of primitive macrophage progenitor cells in mouse bone marrow. Blood 1979 54 : 1446 1450.
16. McNiece IK, Bertoncello I, Kriegler AB, Quesenberry PJ. Colony-forming cells with high proliferative potential (HPP-CFC). Int J Cell Cloning 1990 8 : 146 160.
17. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994 266 : 2011 2015.
18. van Zant G. Studies of hematopoietic stem cells spared by 5-fluorouracil. J Exp Med 1984 159 : 679 690.
19. Engelhardt M, Kumar R, Albanell J et al. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 1997 90 : 182 193.
20. Baerlocher GM, Roth A, Lansdorp PM. Telomeres in hematopoietic stem cells. Ann NY Acad Sci 2003 996 : 44 8.
21. Hiyama K, Hirai Y, Kyoizumi S et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995 155 : 3711 3715.
22. Counter CM, Gupta J, Harley CB et al. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995 85 : 2315 2320.
23. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995 92 : 9082 9086.
24. Wu K, Higashi N, Hansen ER et al. Telomerase activity is increased and telomere length shortened in T cells from blood of patients with atopic dermatitis and psoriasis. J Immunol 2000 165 : 4742 4747.
25. Yu X, Alder JK, Chun JH et al. HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding. Stem Cells 2006 24 : 876 888.
26. Li X, Fan X, Zhang K et al. Influence of psoriatic peripheral blood CD4+ T and CD8+ T lymphocytes on C-myc, Bcl-xL and Ki67 gene expression in keratinocytes. Eur J Dermatol 2007 17 : 392 396.
27. Roussaki-Schulze AV, Kouskoukis C, Petinaki E et al. Evaluation of cytokine serum levels in patients with plaque-type psoriasis. Int J Clin Pharmacol Res 2005 25 : 169 173.
28. Helms C, Cao L, Krueger JG et al. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet 2003 35 : 349 356.
29. Lacaud G, Gore L, Kennedy M et al. Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. Blood 2002 100 : 458 466.
30. Cardier JE, Murphy MJ Jr., Erickson-Miller CL. IL-6 interferes with stimulation of HPP-CFC and large CFU-Mk in conjunction with cytokine combinations from primitive murine marrow cell. Stem Cells 1997 15 : 437 442.
31. Pascher A, Klupp J. Biologics in the treatment of transplant rejection and ischemia/reperfusion injury: new applications for TNFalpha inhibitors? BioDrugs 2005 19 : 211 231.
32. Verfaillie CM. Adhesion receptors as regulators of the hematopoietic process. Blood 1998 92 : 2609 2612.
33. Jacob SE, Nassiri M, Kerdel FA, Vincek V. Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity. Mediators Inflamm 2003 12 : 309 313.
34. Nishibu A, Han GW, Iwatsuki K et al. Overexpression of monocyte-derived cytokines in active psoriasis: a relation to coexistent arthropathy. J Dermatol 1999 21 : 63 70.
35. Ohta Y, Hamada Y, Katsuoka K. Expression of IL-18 in psoriasis. Arch Dermatol Res 2001 293 : 334 342.
36. Zhang K, Liu R, Yin G et al. Differential cytokine secretion of cultured bone marrow stromal cells from patients with psoriasis and healthy volunteers. Eur J Dermatol 2010 20 : 47 53.
37. Peters SO, Kittler EL, Ramshaw HS et al. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 1996 87 : 30 7.
38. Toth ZE, Leker RR, Shahar T et al. The combination of granulocyte colony-stimulating factor and stem cell factor significantly increases the number of bone marrow-derived endothelial cells in brains of mice following cerebral ischemia. Blood 2008 111 : 5544 5552.
39. Chang M, Suen Y, Lee SM et al. Transforming growth factor-beta 1, macrophage inflammatory protein-1 alpha, and interleukin-8 gene expression is lower in stimulated human neonatal compared with adult mononuclear cells. Blood 1994 84 : 118 124.
40. Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 2002 46 : 1 23.
41. Vollmer S, Menssen A, Trommler P et al. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells. Eur J Immunol 1994 24 : 2377 2382.
42. Varnum-Finney B, Purton LE, Yu M et al. The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood 1998 91 : 4084 4091.
43. Walker L, Carlson A, Tan-Pertel HT et al. The Notch receptor and its ligands are selectively expressed during hematopoietic development in the mouse. Stem Cells 2001 19 : 543 552.
44. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999 284 : 770 776.
45. Egan SE, St-Pierre B, Leow CC. Notch receptors, partners and regulators: from conserved domains to powerful functions. Curr Top Microbiol Immunol 1998 228 : 273 324.
46. Davis RL, Turner DL. Vertebrate hairy and enhancer of split related proteins: transcriptional repressors regulating cellular differentiation and embryonic patterning. Oncogene 2001 20 : 8342 8357.
47. Castella P, Sawai S, Nakao K et al. HES-1 repression of differentiation and proliferation in PC12 cells: role for the helix 3-helix 4 domain in transcription repression. Mol Cell Biol 2000 20 : 6170 6183.
48. Kunisato A, Chiba S, Nakagami-Yamaguchi E et al. HES-1 preserves purified hematopoietic stem cells ex vivo and accumulates side population cells in vivo. Blood 2003 101 : 1777 1783.